{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:20:52Z","timestamp":1756383652626,"version":"3.41.2"},"reference-count":13,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T00:00:00Z","timestamp":1615161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Haberland syndrome or encephalocraniocutaneous lipomatosis is a rare ectomesodermal dysgenesis defined by the triad including ocular, skin, and central nervous system involvement, which is commonly unilateral. This disorder is attributed to a post-zygotic mutation responsible for a neural tube and neural crest dysgenesis. We report the case of a 15-year-old female with Haberland syndrome with pharmacoresistant epilepsy who developed a World Health Organization-grade IV glioblastoma. This is the first case of pediatric glioblastoma associated with Haberland syndrome. The previously reported pediatric cases included benign brain tumors. To our knowledge, this is the fifth case of brain tumor associated with encephalocraniocutaneous lipomatosis and the second case of glioblastoma associated with this syndrome. The hypothesis that Haberland syndrome is associated with an increased risk of tumor development is intriguing, although the rarity of the condition is nowadays preventing us from drawing definitive conclusions about this potential link between the two entities. Further studies are needed to establish the real relationship between encephalocraniocutaneous lipomatosis and the risk of brain tumors.<\/jats:p>","DOI":"10.3389\/fped.2021.648717","type":"journal-article","created":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T06:25:48Z","timestamp":1615184748000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Case Report: A Case of Glioblastoma in a Patient With Haberland Syndrome"],"prefix":"10.3389","volume":"9","author":[{"given":"Silvia","family":"Ferranti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iacopo","family":"Sardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena","family":"Guidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Lembo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Grosso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1001\/archneur.1970.00480200050005","article-title":"Encephalocraniocutaneous lipomatosis. A new example of ectomesodermal dysgenesis","volume":"22","author":"Haberland","year":"1970","journal-title":"Arch Neurol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.12659\/AJCR.907685","article-title":"Encephalocraniocutaneous lipomatosis: Haberland syndrome","volume":"18","author":"\u00d6zdogan","year":"2017","journal-title":"Am J Case Rep"},{"key":"B3","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1212\/01.wnl.0000197792.73656.c2","article-title":"PCV chemotherapy for recurrent glioblastoma","volume":"66","author":"Schmidt","year":"2006","journal-title":"Neurology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"523","DOI":"10.4103\/2229\u20135178.193901","article-title":"Encephalocraniocutaneous lipomatosis (Haberland syndrome): a rare case report","volume":"7","author":"Jagati","year":"2016","journal-title":"Indian Dermatol Online J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/BF01203299","article-title":"Ophthalmologic abnormalities in encephalocraniocutaneous lipomatosis","volume":"90","author":"MacLaren","year":"1995","journal-title":"Doc Ophthalmol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/bdra.20080","article-title":"Encephalocraniocutaneous lipomatosis accompanied by maxillary compound odontoma and juvenile angiofibroma: report of a case","volume":"70","author":"Andreadis","year":"2004","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jcms.2005.02.006","article-title":"Mandibular osteoma in the encephalocraniocutaneous lipomatosis","volume":"33","author":"Zieli\u0144ka-Kazmierska","year":"2005","journal-title":"J Craniomaxillofac Surg"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1002\/ajmg.a.31957","article-title":"Encephalocraniocutaneous lipomatosis accompanied by the formation of bone cysts: harboring clues to pathogenesis?","author":"Moog","year":"2007","journal-title":"Am J Med Genet A"},{"key":"B10","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s11060\u2013009-9978\u20131","article-title":"Low-grade astrocytoma in a child with encephalocraniocutaneous lipomatosis","volume":"96","author":"Brassesco","year":"2010","journal-title":"J Neurooncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"E1165","DOI":"10.1227\/NEU.0b013e3181edb24c","article-title":"Papillary glioneuronal tumor present in a patient with encephalocraniocutaneous lipomatosis: case report","volume":"67","author":"Phi","year":"2010","journal-title":"Neurosurgery"},{"key":"B12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00381\u2013011-1601-z","article-title":"Are patients with encephalocraniocutaneous lipomatosis at increased risk of developing low-grade gliomas?","volume":"28","author":"Valera","year":"2012","journal-title":"Childs Nerv Syst"},{"key":"B13","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3892\/mco.2016.996","article-title":"Significant antitumor response of disseminated glioblastoma to bevacizumab resulting in long-term clinical remission in a patient with encephalocraniocutaneous lipomatosis: a case report","volume":"5","author":"Fukaya","year":"2016","journal-title":"Mol Clin Oncol"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.648717\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T06:25:50Z","timestamp":1615184750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.648717\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,8]]},"references-count":13,"alternative-id":["10.3389\/fped.2021.648717"],"URL":"https:\/\/doi.org\/10.3389\/fped.2021.648717","relation":{},"ISSN":["2296-2360"],"issn-type":[{"type":"electronic","value":"2296-2360"}],"subject":[],"published":{"date-parts":[[2021,3,8]]},"article-number":"648717"}}